EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aldosterone synthase inhibitors for hypertension: A breakthrough facing barriers to adoption

Luke J Laffin iD, Steven E Nissen

PLOS Medicine · 2026

DOI: 10.1371/journal.pmed.1004900 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Medicine, 2026. Verfasst von Luke J Laffin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Section of Preventive Cardiology and Rehabilitation, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, United Stat…. Hauptthemen laut MEDLINE: Hypertension, Cytochrome P-450 CYP11B2, Antihypertensive Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite many antihypertensive options, uncontrolled hypertension remains pervasive. Aldosterone synthase inhibitors show robust blood pressure reductions and have the potential to reshape hypertension treatment, though cost and access may impact broad adoption.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionCytochrome P-450 CYP11B2Antihypertensive AgentsHumansBlood Pressure

Substanzen

Cytochrome P-450 CYP11B2Antihypertensive Agents

Autor:innen und Institutionen

  • Section of Preventive Cardiology and Rehabilitation, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, United States of America.
  • Cleveland Clinic Coordinating Center for Clinical Research, Cleveland Clinic Foundation, Cleveland, Ohio, United States of America.

ORCID-Profile: Luke J Laffin

Zitieren

APA

Laffin, L. J., & Nissen, S. E. (2026). Aldosterone synthase inhibitors for hypertension: A breakthrough facing barriers to adoption. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1004900

Vancouver

Laffin LJ, Nissen SE. Aldosterone synthase inhibitors for hypertension: A breakthrough facing barriers to adoption. PLOS Medicine. 2026. doi:10.1371/journal.pmed.1004900

BibTeX
@article{Laffin2026,
  author = {Laffin, Luke J and Nissen, Steven E},
  title = {Aldosterone synthase inhibitors for hypertension: A breakthrough facing barriers to adoption},
  journal = {PLOS Medicine},
  year = {2026},
  doi = {10.1371/journal.pmed.1004900}
}
Kostenlos starten →